Development of adenovirus immobilization strategies for in situ gene therapy

Journal of Gene Medicine

Volumn 10, Issue 10, 2008, Pages 1102-1112

  Hu, Wei Wen ^a   Lang, Michael W ^a   Krebsbach, Paul H ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Adenovirus; Avidin biotin; Chitosan; Gene delivery; Surface modification; Tissue engineering

Indexed keywords

ADENOVIRUS VECTOR; ALKALINE PHOSPHATASE; AVIDIN; BETA GALACTOSIDASE; CHITOSAN; BIOTIN;

ARTICLE; BIOTINYLATION; CONJUGATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; GENE LOCATION; GENE SEQUENCE; GENETIC TRANSDUCTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN IMMOBILIZATION; PROTEIN INTERACTION; PROTEIN TRANSPORT; SCANNING ELECTRON MICROSCOPY; TISSUE REGENERATION; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY; ADENOVIRUS; CHEMISTRY; GENE THERAPY; GENE TRANSFER; GENE VECTOR; GENETICS; METABOLISM; METHODOLOGY;

ADENOVIRIDAE;

ADENOVIRIDAE; AVIDIN; BIOTIN; BIOTINYLATION; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; MICROSCOPY, ELECTRON, SCANNING; TRANSDUCTION, GENETIC;

EID: 58149180956     PISSN: 1099498X     EISSN: 15212254     Source Type: Journal    
DOI: 10.1002/jgm.1233     Document Type: Article

References (37)

1. Pickles RJ, McCarty D, Matsui H, et al. Limited entry of adenovirus vectors into well-differentiated airway epithelium is responsible for inefficient gene transfer. J Virol 1998; 72: 6014-6023.
2. Alden TD, Pittman DD, Hankins GR, et al. In vivo endochondral bone formation using a bone morphogenetic protein 2 adenoviral vector. Hum Gene Ther 1999; 10: 2245-2253.
3. Musgrave DS, Bosch P, Ghivizzani S, et al. Adenovirus-mediated direct gene therapy with bone morphogenetic protein-2 produces bone. Bone 1999; 24: 541-547.
4. Okubo Y, Bessho K, Fujimura K, Iizuka T, Miyatake SI. Osteoinduction by bone morphogenetic protein-2 via adenoviral vector under transient immunosuppression. Biochem Biophys Res Commun 2000; 267: 382-387.
5. Kass-Eisler A, Falck-Pedersen E, Elfenbein DH, et al. The impact of developmental stage, route of administration and the immune system on adenovirus-mediated gene transfer. Gene Ther 1994; 1: 395-402.
6. Ochiya T, Nagahara S, Sano A, Itoh H, Terada M. Biomaterials for gene delivery: atelocollagen-mediated controlled release of molecular medicines. Curr Gene Ther 2001; 1: 31-52.
7. Beer SJ, Matthews CB, Stein CS, et al. Poly (lactic-glycolic) acid copolymer encapsulation of recombinant adenovirus reduces immunogenicity in vivo. Gene Ther 1998; 5: 740-746.
8. Jang JH, Houchin TL, Shea LD. Gene delivery from polymer scaffolds for tissue engineering. Expert Rev Med Devices 2004; 1: 127-138.
9. Bengali Z, Rea JC, Shea LD. Gene expression and internalization following vector adsorption to immobilized proteins: dependence on protein identity and density. J Gene Med 2007; 9: 668-678.
10. Hu WW, Wang Z, Hollister SJ, Krebsbach PH. Localized viral vector delivery to enhance in situ regenerative gene therapy. Gene Ther 2007; 14: 891-901.
11. Onishi H, Machida Y. Biodegradation and distribution of water-soluble chitosan in mice. Biomaterials 1999; 20: 175-182.
12. Rao SB, Sharma CP. Use of chitosan as a biomaterial: studies on its safety and hemostatic potential. J Biomed Mater Res 1997; 34: 21-28.
13. Aspden TJ, Mason JD, Jones NS, et al. Chitosan as a nasal delivery system: the effect of chitosan solutions on in vitro and in vivo mucociliary transport rates in human turbinates and volunteers. J Pharm Sci 1997; 86: 509-513.
14. Suh JK, Matthew HW. Application of chitosan-based polysaccharide biomaterials in cartilage tissue engineering: a review. Biomaterials 2000; 21: 2589-2598.
15. Zhang Y, Zhang M. Calcium phosphate/chitosan composite scaffolds for controlled in vitro antibiotic drug release. J Biomed Mater Res 2002; 62: 378-386.
16. Li Z, Ramay HR, Hauch KD, Xiao D, Zhang M. Chitosan-alginate hybrid scaffolds for bone tissue engineering. Biomaterials 2005; 26: 3919-3928.
17. Levy RJ, Song C, Tallapragada S, et al. Localized adenovirus gene delivery using antiviral IgG complexation. Gene Ther 2001; 8: 659-667.
18. Klugherz BD, Song C, DeFelice S, et al. Gene delivery to pig coronary arteries from stents carrying antibody-tethered adenovirus. Hum Gene Ther 2002; 13: 443-454.
19. Mei L, Jin X, Song C, Wang M, Levy RJ. Immobilization of gene vectors on polyurethane surfaces using a monoclonal antibody for localized gene delivery. J Gene Med 2006; 8: 690-698.
20. Green NM. Avidin. 1. The use of (14-C)biotin for kinetic studies and for assay. Biochem J 1963; 89: 585-591.
21. Yao D, Vlessidis AG, Evmiridis NP. Microdialysis sampling and monitoring of uric acid in vivo by a chemiluminescence reaction and an enzyme on immobilized chitosan support membrane. Anal Chim Acta 2003; 478: 23-30.
22. Parrott MB, Adams KE, Mercier GT, et al. Metabolically biotinylated adenovirus for cell targeting, ligand screening, and vector purification. Mol Ther 2003; 8: 688-700.
23. Hobson DA, Pandori MW, Sano T. In situ transduction of target cells on solid surfaces by immobilized viral vectors. BMC Biotechnol 2003; 3: 4.
24. Nanci A, Wuest JD, Peru L, et al. Chemical modification of titanium surfaces for covalent attachment of biological molecules. J Biomed Mater Res 1998; 40: 324-335.
25. Vijayendran RA, Leckband DE. A quantitative assessment of heterogeneity for surface-immobilized proteins. Anal Chem 2001; 73: 471-480.
26. Sips R. On the structure of a catalyst surface. J Chem Phys 1948; 16: 490-495.
27. Dimmock NJ, Primrose SB (eds). Introduction to Modern Virology. Blackwell Press: London, 1994; 345.
28. Bajaj B, Lei P, Andreadis ST. High efficiencies of gene transfer with immobilized recombinant retrovirus: kinetics and optimization. Biotechnol Prog 2001; 17: 587-596.
29. Hanenberg H, Xiao XL, Dilloo D, et al. Colocalization of retrovirus and target cells on specific fibronectin fragments increases genetic transduction of mammalian cells. Nat Med 1996; 2: 876-882.
30. Lu B, Smyth MR, O'Kennedy R. Oriented immobilization of antibodies and its applications in immunoassays and immunosensors. Analyst 1996; 121: 29R-32R.
31. Yeung C, Leckband D. Molecular level characterization of microenvironmental influences on the properties of immobilized proteins. Langmuir 1997; 13: 6746-6754.
32. Yeung C, Purves T, Kloss AA, et al. Cytochrome c recognition of immobilized, orientational variants of cytochrome b(5): direct force and equilibrium binding measurements. Langmuir 1999; 15: 6829-6836.
33. Firestone MA, Shank ML, Sligar SG, Bohn PW. Film architecture in biomolecular assemblies. Effect of linker on the orientation of genetically engineered surface-bound proteins. J Am Chem Soc 1996; 118: 9033-9041.
34. Shriver-Lake LC, Donner B, Edelstein R, et al. Antibody immobilization using heterobifunctional crosslinkers. Biosens Bioelectron 1997; 12: 1101-1106.
35. Anderson GP, Jacoby MA, Ligler FS, King KD. Effectiveness of protein A for antibody immobilization for a fiber optic biosensor. Biosens Bioelectron 1997; 12: 329-336.
36. Lu B, Smyth MR, Okennedy R. Immunological activities of IgG antibody on pre-coated Fc receptor surfaces. Anal Chim Acta 1996; 331: 97-102.
37. ++ surface. J Memb Sci 2006; 280: 553-559.